MedPath
FDA Approval

Rimantadine Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 12, 2011
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Rimantadine(100 mg in 1 1)

Manufacturing Establishments3

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Impax Laboratories Inc

H.J. Harkins Company, Inc.

790947167

Global Pharmaceuticals, Division of Impax Laboratories Inc.

H.J. Harkins Company, Inc.

116732830

Impax Laboratories Taiwan Inc.

H.J. Harkins Company, Inc.

656139511

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Rimantadine Hydrochloride

Product Details

NDC Product Code
52959-305
Application Number
ANDA076132
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 12, 2011
Code: JEI07OOS8YClass: ACTIBQuantity: 100 mg in 1 1
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1AClass: IACT
© Copyright 2025. All Rights Reserved by MedPath